Structural Modification of Sesquiterpene Lactones via Michael Addition: Improved Bioactivity and Pharmacokinetics. [PDF]
Ha MW, Kang J, Lee S, Paek SM.
europepmc +1 more source
Emerging Strategies for <i>meta</i>-Heteroatom Functionalization of Pyridines. [PDF]
Francisco TN +2 more
europepmc +1 more source
Trinuclear Heptamethine Dyes for Shortwave Infrared In Vivo Imaging. [PDF]
Garcia CA +6 more
europepmc +1 more source
Frame-Shifted Synthesis of Oligoheterocycles as a Platform for Molecular Design. [PDF]
Bastick KAC +6 more
europepmc +1 more source
Regioselective [3 + 2] cycloaddition reactions of the phosphorus and arsenic analogues of the thiocyanate anion. [PDF]
Baltrun M +5 more
europepmc +1 more source
To make exceptionally effective drugs, thinking “outside the binding site” is required. This work reveals that counterintuitive targeting of a kinase‐conserved region can lead to highly selective binding. Inhibitor discovery coupled to x‐ray crystallography shows that a network of noncanonical interactions and long‐range effects of distant unique amino
Nico J. Seidler +20 more
wiley +1 more source
C6-ROMP Enabled by Structure-Guided Monomer Design for Chemically Recyclable Polymers. [PDF]
Choi K, Choi W, Chung M, Im B, Hong SH.
europepmc +1 more source
High-Performance Photochromic Diarylethene with a Boron-Nitrogen Heterocyclic Ethene Bridge. [PDF]
Zhang C, Dai Y, Chen Y, Dong S, Wang J.
europepmc +1 more source
Novel Compounds as Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy. [PDF]
Sabnis RW.
europepmc +1 more source
Fused 3D boron heterocycles <i>via</i> EnT catalysis: synthesis, modification and validation as beta-lactamase inhibitors. [PDF]
Kortman HM +7 more
europepmc +1 more source

